ARCHIVES

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

House Authorizes $30M For Pediatric Cancer Research.

June 13, 2008

MRI, 3D Ultrasound Combination Can Guide Prostate Biopsies

December 28, 2012

NCI Developing Plan To Replace Research Contracts At Academic Institutions With “Program Grants”

February 22, 1974

NIH Deputy Director Ruth Kirschstein Plans Transition To Senior Advisor

October 4, 2002

Private Institute Commits $1 Million Pick Up some NIH Grants Left Unfunded

April 19, 1985

In Brief: Cancer Act Extension, Training Bill Breezing Through Congress; Army Causes Ft. Detrick Flap

July 5, 1974